Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications
Ploutarchos Pastras, Ioanna Aggeletopoulou, Vasiliki Psalti, Christos Triantos · 2026
Read Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications by Ploutarchos Pastras, Ioanna Aggeletopoulou, Vasiliki Psalti, Christos Triantos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210724.txt.
Description
Ploutarchos Pastras and co-authors present a 2026 review separating two gut disorders that share a microbial theme. Irritable bowel syndrome and inflammatory bowel disease both involve disturbed gut bacteria, yet the disturbance means different things in each. The review sorts the pathways by where they truly belong.
In bowel disease of the inflammatory kind, microbes tie into immune misfiring, a leaky gut wall, and lasting inflammation, with diversity loss a hallmark. Irritable bowel talks more through the gut-brain axis, mast cells, and bacterial byproducts that stir nerves. Some actors, like an invasive gut bacterium and the gut's Paneth cells, appear only in the inflammatory story. Biomarkers differ accordingly. The authors map what that means for choosing probiotics, antibiotics, or transplants.
Catalog record
| CREATOR | Ploutarchos Pastras, Ioanna Aggeletopoulou, Vasiliki Psalti, Christos Triantos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |